Gene · 4144
Papers1,624
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,624
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MTAP-Null Tumors: A Comprehensive Review on Synthetic Vulnerabilities and Therapeutic Strategies. | Cells | 2025 | 41439984 | PubTator, text mining | PubMed |
| MAT2A promotes atherosclerotic plaque vulnerability by mediating epigenetic reprogramming of macrophages. | Nat Commun | 2025 | 41402252 | PubTator, text mining | PubMed |
| A novel role of secreted methionine adenosyltransferase α2 in colorectal liver metastases. | J Exp Clin Cancer Res | 2025 | 41331630 | PubTator, text mining | PubMed |
| Status of Dutch Elm Disease Fungus Ophiostoma novo-ulmi and Assessment of Its Temporal Variability in Croatia. | Microb Ecol | 2025 | 41291103 | PubTator, text mining | PubMed |
| Furo[2,3-f]quinazolin-7(6H)-one Derivatives as Potent, Selective, and Orally Bioavailable MAT2A Inhibitors for MTAP-Deficient Cancer Therapy. | J Med Chem | 2025 | 41247922 | PubTator, text mining | PubMed |
| Unfolded protein response kinase PERK supports survival and metastasis of circulating tumor cell clusters via SAM synthesis and H3K4me3-dependent PDGFB signaling. | Cancer Commun (Lond) | 2025 | 41212905 | PubTator, text mining | PubMed |
| Targeting MAT2A synergistically induces DNA damage in osteosarcoma cells through EZH2-mediated H3K27me3 modification. | J Orthop Translat | 2025 | 41146859 | PubTator, text mining | PubMed |
| Methionine-MAT2A-SAM axis controls lipid levels by regulating ACSL4. | Oncol Lett | 2025 | 41078715 | PubTator, text mining | PubMed |
| Enzymatic synthesis of stable isotope-labeled SAM for screening hMAT2A inhibitors by using matrix-assisted laser desorption/ionization mass spectrometry. | Analyst | 2025 | 41059674 | PubTator, text mining | PubMed |
| The Expanding Genetic Architecture of Arteriopathies: From Canonical TAAD Genes to Emerging Connective Tissue and Signaling Pathways. | Med Sci (Basel) | 2025 | 40981152 | PubTator, text mining | PubMed |
| SUMO E1 covalent allosteric inhibitors upregulate polyamine synthesis via the MAT2A-AdoMetDC axis. | Bioorg Chem | 2025 | 40884915 | PubTator, text mining | PubMed |
| Widespread specific intron retention events in nuclear RNA complexes identified by sedimentation analysis of pluripotent cellular extracts. | Genome Res | 2025 | 40858361 | PubTator, text mining | PubMed |
| Structures and mechanisms of U6 snRNA m6A modification by METTL16. | Nat Commun | 2025 | 40841561 | PubTator, text mining | PubMed |
| How Well Do Molecular Dynamics Force Fields Model Peptides? A Systematic Benchmark Across Diverse Folding Behaviors. | bioRxiv | 2025 | 40766644 | PubTator, text mining | PubMed |
| Modulating the serine metabolism in human differentiated astrocytes: an integrated multi omics approach. | Front Cell Neurosci | 2025 | 40761926 | PubTator, text mining | PubMed |
| Necroptosis in cancer: insight from epigenetic, post-transcriptional and post-translational modifications. | J Hematol Oncol | 2025 | 40739259 | PubTator, text mining | PubMed |
| Persicaria minor F-box protein, PmFBK2 targeted by miR156a in response to MeJA treatment, potentially affects stress-related proteins. | J Plant Physiol | 2025 | 40683030 | PubTator, text mining | PubMed |
| The catalytic efficiency of METTL16 affects cellular processes by governing the intracellular S-adenosylmethionine setpoint. | Cell Rep | 2025 | 40644296 | PubTator, text mining | PubMed |
| Prognostic Role of MTAP Loss in Cholangiocarcinoma. | JCO Precis Oncol | 2025 | 40638878 | PubTator, text mining | PubMed |
| Polyamines at the crossroad between cell metabolism and epigenetic regulation in acute leukemias. | Cell Death Discov | 2025 | 40603833 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4144/papers?page=4